Literature DB >> 28814242

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance.

Ramya Nuti1, Nerella S Goud1, A Prasanth Saraswati1, Ravi Alvala2, Mallika Alvala1.   

Abstract

BACKGROUND: Antimicrobial resistance (AMR) has posed a serious threat to global public health and it requires immediate action, preferably long term. Current drug therapies have failed to curb this menace due to the ability of microbes to circumvent the mechanisms through which the drugs act. From the drug discovery point of view, the majority of drugs currently employed for antimicrobial therapy are small molecules. Recent trends reveal a surge in the use of peptides as drug candidates as they offer remarkable advantages over small molecules.
METHODS: Newer synthetic strategies like organometalic complexes, Peptide-polymer conjugates, solid phase, liquid phase and recombinant DNA technology encouraging the use of peptides as therapeutic agents with a host of chemical functions, and tailored for specific applications. In the last decade, many peptide based drugs have been successfully approved by the Food and Drug Administration (FDA). This success can be attributed to their high specificity, selectivity and efficacy, high penetrability into the tissues, less immunogenicity and less tissue accumulation. Considering the enormity of AMR, the use of Antimicrobial Peptides (AMPs) can be a viable alternative to current therapeutics strategies. AMPs are naturally abundant allowing synthetic chemists to develop semi-synthetics peptide molecules. AMPs have a broad spectrum of activity towards microbes and they possess the ability to bypass the resistance induction mechanisms of microbes. RESULT: The present review focuses on the potential applications of AMPs against various microbial disorders and their future prospects. Several resistance mechanisms and their strategies have also been discussed to highlight the importance in the current scenario.
CONCLUSION: Breakthroughs in AMP designing, peptide synthesis and biotechnology have shown promise in tackling this challenge and has revived the interest of using AMPs as an important weapon in fighting AMR. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Anti-microbial resistance; anti-microbial; development; peptides; resistance mechanisms; tackling resistance

Mesh:

Substances:

Year:  2017        PMID: 28814242     DOI: 10.2174/0929867324666170815102441

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  23 in total

1.  Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity.

Authors:  Yongqing Liu; Tengfei Shen; Liangliang Chen; Jiangfei Zhou; Chen Wang
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

2.  Activity and characterization of a pH-sensitive antimicrobial peptide.

Authors:  Morgan A Hitchner; Luis E Santiago-Ortiz; Matthew R Necelis; David J Shirley; Thaddeus J Palmer; Katharine E Tarnawsky; Timothy D Vaden; Gregory A Caputo
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-05-08       Impact factor: 3.747

Review 3.  Role of Vaginal Mucosa, Host Immunity and Microbiota in Vulvovaginal Candidiasis.

Authors:  Subatrra Nair Balakrishnan; Haizat Yamang; Michael C Lorenz; Shu Yih Chew; Leslie Thian Lung Than
Journal:  Pathogens       Date:  2022-05-25

4.  Analysis of the Ribonuclease A Superfamily of Antimicrobial Peptides in Patients Undergoing Chronic Peritoneal Dialysis.

Authors:  Neha Dhingra Pottanat; Amy C Brook; Maria Bartosova; Hanna Cortado; Sudipti Gupta; Birong Li; Ashley R Jackson; Martin Vonau; Shira Cohen; Maria Ferrara; Christina B Ching; John David Spencer; Annelie Brauner; Donald J Fraser; Claus Peter Schmitt; Matthias Eberl; Rose Ayoob; Brian Becknell
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

Review 5.  Nanosystems as Vehicles for the Delivery of Antimicrobial Peptides (AMPs).

Authors:  Ángela Martin-Serrano; Rafael Gómez; Paula Ortega; F Javier de la Mata
Journal:  Pharmaceutics       Date:  2019-09-02       Impact factor: 6.321

Review 6.  Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus.

Authors:  Yunlei Guo; Guanghui Song; Meiling Sun; Juan Wang; Yi Wang
Journal:  Front Cell Infect Microbiol       Date:  2020-03-17       Impact factor: 5.293

Review 7.  Strategies in Translating the Therapeutic Potentials of Host Defense Peptides.

Authors:  Darren Shu Jeng Ting; Roger W Beuerman; Harminder S Dua; Rajamani Lakshminarayanan; Imran Mohammed
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

8.  Characterization of the transcriptional response of Candida parapsilosis to the antifungal peptide MAF-1A.

Authors:  Rong Cheng; Wei Li; Klarke M Sample; Qiang Xu; Lin Liu; Fuxun Yu; Yingjie Nie; Xiangyan Zhang; Zhenhua Luo
Journal:  PeerJ       Date:  2020-09-07       Impact factor: 2.984

9.  A novel antimicrobial polymer efficiently treats multidrug-resistant MRSA-induced bloodstream infection.

Authors:  Xu Chen; Weiyang Lou; Jingxing Liu; Bisha Ding; Weimin Fan; Jun Hong
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

10.  Pan-Drug Resistant Acinetobacter baumannii, but Not Other Strains, Are Resistant to the Bee Venom Peptide Mellitin.

Authors:  Rangel Karyne; Guilherme Curty Lechuga; André Luis Almeida Souza; João Pedro Rangel da Silva Carvalho; Maria Helena Simões Villas Bôas; Salvatore Giovanni De Simone
Journal:  Antibiotics (Basel)       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.